ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2,1,Pneumothorax spontaneous,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
4,1,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
6,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
7,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
9,2,Circumoral oedema,Angioedemas,Angioedema and urticaria,Skin,N
9,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
9,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
10,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,3,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
10,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10,5,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
11,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
11,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
11,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11,4,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
11,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
11,6,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
11,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
11,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
11,9,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,10,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,11,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,12,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
11,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
12,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
12,3,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
13,1,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
13,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
14,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
15,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
18,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
20,1,Pneumothorax spontaneous,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
21,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
21,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
23,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
24,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
24,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
25,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
26,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
26,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
27,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
27,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
27,3,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
28,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
29,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
30,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
30,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
30,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
31,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
33,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
34,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
35,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
36,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
37,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
37,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
38,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
38,2,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
38,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
39,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
39,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,7,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
39,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
39,9,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
40,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
41,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
42,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
43,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
43,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
43,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
44,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
45,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
45,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
45,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
46,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
47,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
48,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
48,3,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
48,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
50,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
51,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
51,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
52,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
53,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
54,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
54,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
55,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
55,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
56,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
57,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
57,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
57,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
57,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
58,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
58,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
58,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
59,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
60,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
61,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
61,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
61,3,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
61,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
62,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
63,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
63,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
63,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
64,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
64,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
65,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
66,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
66,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
69,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
69,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
69,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
70,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
71,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
71,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,3,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
72,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
73,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
73,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
76,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
77,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
78,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
81,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
85,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
86,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
88,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
88,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
89,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
90,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
90,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
90,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
90,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
90,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
90,6,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
90,7,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
90,8,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
90,9,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,10,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
90,11,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
90,12,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,13,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
90,14,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
90,15,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,16,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
90,17,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
90,18,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
90,19,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
90,20,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
90,21,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
90,22,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
90,23,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
90,24,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
90,25,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
90,26,Headache,Headaches NEC,Headaches,Nerv,N
90,27,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
90,28,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
90,29,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
90,30,Increased upper airway secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
90,31,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
90,32,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
90,33,Jaw cyst,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
90,34,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
90,35,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
90,36,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
90,37,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
90,38,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
90,39,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
90,40,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
90,41,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
90,42,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
90,43,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
90,44,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
90,45,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
90,46,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
90,47,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
90,48,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,49,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
90,50,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
90,51,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
90,52,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
90,53,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
90,54,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
90,55,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
90,56,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,57,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
90,58,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
90,59,Total lung capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
90,60,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
90,61,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
90,62,Upper-airway cough syndrome,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
90,63,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
90,64,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
90,65,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
91,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
92,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
92,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
93,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
93,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
95,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
95,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
95,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
95,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
96,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
99,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
99,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,3,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
100,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
100,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
101,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
104,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
104,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
105,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
106,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,2,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
107,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
107,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
109,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
109,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
109,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
109,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
109,6,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
109,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
110,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
111,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
111,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
112,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
112,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
112,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
112,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,6,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,7,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
112,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
112,9,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
113,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
114,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
115,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
115,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
116,2,Gallbladder polyp,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
116,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
117,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
117,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
117,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
117,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
117,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
117,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
118,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
118,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
118,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
118,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
118,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
118,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
118,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
120,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,Y
121,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
121,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
122,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
123,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
123,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
123,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
123,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
123,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
123,6,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
123,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
123,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
124,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
125,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
125,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
125,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
125,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
125,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
126,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
127,1,Headache,Headaches NEC,Headaches,Nerv,N
127,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
127,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
128,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
128,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
128,3,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
128,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
128,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
128,6,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
128,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
128,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,10,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
128,11,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
128,12,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
128,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
128,14,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
128,15,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
128,16,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
128,17,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
128,18,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
128,19,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
128,20,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
128,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,22,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,23,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,24,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
128,25,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,26,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,27,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
128,28,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
128,29,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
129,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
129,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
130,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
130,3,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
130,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
132,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
133,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
133,2,Oesophageal neoplasm,Oesophageal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
134,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
135,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,Y
136,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
136,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
136,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
139,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
139,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
139,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
140,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
141,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
142,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
142,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
142,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
143,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
143,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
144,1,Lip neoplasm,Lip and oral cavity neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
144,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
144,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
145,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
146,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
146,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
148,1,Antineutrophil cytoplasmic antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
148,2,Antineutrophil cytoplasmic antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
148,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
149,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
150,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
150,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
150,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
151,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
151,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
151,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
151,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
151,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
151,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
151,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
151,9,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
151,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
152,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
152,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
153,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
154,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
155,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
156,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
156,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
156,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
156,4,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
156,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
157,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
158,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
159,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
159,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
159,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
160,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
160,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
160,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
161,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
163,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
164,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
165,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
165,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
165,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
166,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
167,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
168,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
168,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
169,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
169,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
169,3,Headache,Headaches NEC,Headaches,Nerv,N
169,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
169,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
171,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,3,Forced vital capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
172,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
173,1,Eczema asteatotic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
173,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
173,3,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
173,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
173,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
173,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
173,8,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
173,9,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
173,10,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
173,11,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
174,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
175,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,3,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
176,1,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
177,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
177,2,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
178,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
179,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
180,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
180,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
180,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
181,1,Cold type haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
182,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
183,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
184,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
184,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
185,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
186,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
186,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
186,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
187,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
188,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
189,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
190,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
191,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
191,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
193,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
193,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
193,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
193,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
193,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
193,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
194,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
194,2,Blood electrolytes increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
194,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
194,4,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
194,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
194,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
194,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
194,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
194,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
195,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
196,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
197,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
197,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
197,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
197,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
197,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
197,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
197,7,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
197,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
198,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
199,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
199,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
199,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
200,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
200,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
201,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
202,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
202,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
202,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
202,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
202,5,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
202,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
202,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
202,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
203,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
203,2,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
204,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
205,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
205,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
206,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
207,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
207,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
209,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
209,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
210,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
210,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
211,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
212,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
213,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
213,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
213,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
213,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
215,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
216,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
217,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
217,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
218,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
219,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
219,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
219,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
219,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
221,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
221,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
223,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
223,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
224,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
225,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
226,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
227,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
228,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
228,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
228,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
228,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
228,5,Monocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
228,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
229,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
231,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
232,1,Cardiovascular symptom,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
232,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
232,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
233,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
234,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
235,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
236,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
236,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
236,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
236,4,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
236,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
236,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
237,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
238,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
238,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
238,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
238,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
238,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
238,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
240,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
240,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
241,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
242,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
243,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
243,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
243,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
243,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
245,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
245,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
245,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
245,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
245,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
245,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
246,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
246,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
246,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
247,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
248,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
249,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
250,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
250,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
251,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
251,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
252,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
254,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
255,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
256,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
257,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
257,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
258,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
259,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
260,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
262,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
262,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
262,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
262,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
262,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
262,6,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
262,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
263,1,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
264,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
265,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
266,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
267,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
267,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
267,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
267,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
267,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
267,6,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
267,7,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
267,8,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
267,9,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
267,10,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
267,11,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
267,12,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,13,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
267,14,Death,Death and sudden death,Fatal outcomes,Genrl,Y
267,15,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
267,16,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
267,17,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,18,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
267,19,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
267,20,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
267,21,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
267,22,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
267,23,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
267,24,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
267,25,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
267,26,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
267,27,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
267,28,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,29,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
267,30,Headache,Headaches NEC,Headaches,Nerv,N
267,31,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
267,32,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
267,33,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
267,34,Increased upper airway secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
267,35,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
267,36,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
267,37,Jaw cyst,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
267,38,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
267,39,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
267,40,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
267,41,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
267,42,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
267,43,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
267,44,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
267,45,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
267,46,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
267,47,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
267,48,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
267,49,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
267,50,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
267,51,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
267,52,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
267,53,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
267,54,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
267,55,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
267,56,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
267,57,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
267,58,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
267,59,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
267,60,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
267,61,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
267,62,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,63,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
267,64,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,65,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
267,66,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
267,67,Total lung capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
267,68,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
267,69,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
267,70,Upper-airway cough syndrome,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
267,71,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
267,72,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
267,73,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
268,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,1,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
271,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
273,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
273,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
273,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
274,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
274,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
274,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
274,4,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
274,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
274,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
274,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
274,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
274,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,1,Koilonychia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
276,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
277,1,Koilonychia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
277,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
278,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
279,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
280,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
280,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
280,3,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
280,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
281,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
282,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
284,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
285,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
285,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
286,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
287,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
288,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
289,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
290,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
292,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
293,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
294,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
296,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
297,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
298,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
299,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
300,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
303,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
303,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
303,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
303,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
304,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
304,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
304,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
304,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
304,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
304,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
305,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
307,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
307,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
308,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
310,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
310,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
312,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
313,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
314,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
316,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
317,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
319,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
320,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
321,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
323,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
324,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
325,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
326,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
326,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
327,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
328,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
330,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
331,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
332,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
334,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
334,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
334,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
334,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
335,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
336,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
337,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
339,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
340,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
341,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
344,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
345,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
347,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
348,1,Gastric pH decreased,Gastrointestinal function diagnostic procedures,Gastrointestinal investigations,Inv,N
349,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
350,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
351,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
352,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
353,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
361,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
362,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
363,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
365,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
366,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
367,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
368,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
369,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
369,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
370,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
372,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
373,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
375,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
375,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
376,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
377,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
378,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
378,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
379,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
379,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
380,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
380,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,4,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
381,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
382,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
382,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
382,4,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
382,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
383,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
384,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
386,1,Product selection error,Product selection errors and issues,Medication errors and other product use errors and issues,Inj&P,N
387,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
388,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
389,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
389,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
390,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
395,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
396,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
398,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
399,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
399,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
399,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
399,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
399,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
399,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
399,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
399,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,9,Performance fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
400,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
402,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
404,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
405,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
406,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
407,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
408,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
409,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
411,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
412,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
413,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
414,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
415,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
416,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
417,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
419,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,1,Discontinued product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
421,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
421,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
423,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
425,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
426,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
427,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
427,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
427,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
427,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
427,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
428,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
429,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
430,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
431,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
432,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
433,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
434,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
434,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
435,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
436,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
437,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
438,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
439,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
440,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
441,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
442,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
443,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
444,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
445,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
446,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
447,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
448,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
449,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
450,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
451,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
453,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
454,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
455,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
456,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
457,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
458,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
459,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
460,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
462,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
463,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
464,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
464,2,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
465,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
466,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
467,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
467,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
468,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
469,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
469,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
469,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
469,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
469,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
470,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
470,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
471,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
472,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
472,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
472,3,Headache,Headaches NEC,Headaches,Nerv,N
473,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
473,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
474,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
475,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
476,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
477,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
478,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
479,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
481,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
482,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
483,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
484,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
485,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
487,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
488,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
489,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
490,1,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
491,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
492,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
493,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
494,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
495,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
495,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
496,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
497,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
498,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
498,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
499,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
499,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
500,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
501,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
501,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
501,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
501,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
501,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
501,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
501,7,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
501,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
501,9,Headache,Headaches NEC,Headaches,Nerv,N
501,10,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
502,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
503,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
504,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
505,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
505,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
505,3,Orthostatic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
506,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
507,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
508,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
509,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
510,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
511,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
512,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
513,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
514,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
515,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
516,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
517,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
519,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
520,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
522,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
524,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
527,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
528,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
529,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
530,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
532,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
534,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
535,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
536,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
539,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
540,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
542,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
543,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
544,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
545,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
546,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
547,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
548,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
549,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
549,2,Diabetic complication,Diabetic complications NEC,Diabetic complications,Metab,N
550,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
551,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
552,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
553,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
555,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
556,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
557,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
557,2,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
557,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
557,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
558,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
559,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
560,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
561,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
562,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
563,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
564,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
564,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
565,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
567,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
568,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
568,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
569,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
570,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
571,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
572,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
572,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
573,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
574,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
575,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
576,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
577,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
578,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
579,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
580,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
580,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
580,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
581,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
583,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
584,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
585,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
586,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
587,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
588,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
589,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
589,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
590,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
592,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
593,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
594,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
595,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
596,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
597,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
599,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
599,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
600,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
601,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
602,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
603,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
604,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
605,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
606,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
607,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
608,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
608,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
609,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
610,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
611,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
612,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
613,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
614,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
614,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
614,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
614,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
615,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
616,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
617,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
618,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
619,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,1,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
621,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
622,1,Headache,Headaches NEC,Headaches,Nerv,N
623,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
623,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
624,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
625,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
626,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
627,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
628,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
628,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
629,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
630,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
631,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
631,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
631,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
631,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
631,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
632,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
